Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

Combined umbilical cord blood and bone marrow from HLA-identical sibling donors for hematopoietic stem cell transplantation in children with hemoglobinopathies.

  • Read more about Combined umbilical cord blood and bone marrow from HLA-identical sibling donors for hematopoietic stem cell transplantation in children with hemoglobinopathies.

Impact of decreased heparin dose for flush-lock of implanted venous access ports in pediatric oncology patients.

  • Read more about Impact of decreased heparin dose for flush-lock of implanted venous access ports in pediatric oncology patients.

Renal medullary carcinoma in an adolescent with sickle cell anemia.

  • Read more about Renal medullary carcinoma in an adolescent with sickle cell anemia.

A novel mutation in protein C gene (PROC) causing severe phenotype in neonatal period.

  • Read more about A novel mutation in protein C gene (PROC) causing severe phenotype in neonatal period.

Neuroblastoma in older children, adolescents and young adults: a report from the International Neuroblastoma Risk Group project.

  • Read more about Neuroblastoma in older children, adolescents and young adults: a report from the International Neuroblastoma Risk Group project.

Current treatment and outcome for childhood acute leukemia in Tanzania.

  • Read more about Current treatment and outcome for childhood acute leukemia in Tanzania.

Comparison of Latino and non-Latino patients with Ewing sarcoma.

  • Read more about Comparison of Latino and non-Latino patients with Ewing sarcoma.

Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: a report from the New Approaches to Neuroblastoma Therapy (NANT) consortium.

  • Read more about Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: a report from the New Approaches to Neuroblastoma Therapy (NANT) consortium.

The palatability and tolerability of deferasirox taken with different beverages or foods.

  • Read more about The palatability and tolerability of deferasirox taken with different beverages or foods.

Acute changes in blood pressure in patients with neuroblastoma treated with ¹³¹I-metaiodobenzylguanidine (MIBG).

  • Read more about Acute changes in blood pressure in patients with neuroblastoma treated with ¹³¹I-metaiodobenzylguanidine (MIBG).

Pagination

  • Previous page ‹‹
  • Page 11
  • Next page ››
Subscribe to Pediatric blood & cancer

Pediatrics Home

MAKE A GIFT

© 2026 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                   Accessibility  Privacy Policy  Terms of Use  A-Z Website List